Compounds > dihydroxyphenylalanine
Page last updated: 2024-10-18

dihydroxyphenylalanine and Shock, Cardiogenic

dihydroxyphenylalanine has been researched along with Shock, Cardiogenic in 3 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cunescu, V1
Pârvu, V1
Lozano, JR1
Corday, E1
Carrasco, HA2
Lang, TW2
Meerbaum, S2
Lozano, J1

Reviews

1 review available for dihydroxyphenylalanine and Shock, Cardiogenic

ArticleYear
[Drug iatrogenesis in cardiology].
    Medicina interna, 1971, Volume: 23, Issue:1

    Topics: Antidepressive Agents; Antihypertensive Agents; Appetite Depressants; Blood Coagulation Disorders; C

1971

Other Studies

2 other studies available for dihydroxyphenylalanine and Shock, Cardiogenic

ArticleYear
Pharmacodynamic application of L-dopa in cardiogenic shock.
    American heart journal, 1972, Volume: 83, Issue:3

    Topics: Animals; Aorta; Blood Pressure; Coronary Circulation; Dihydroxyphenylalanine; Disease Models, Animal

1972
L-dopa: its effect on the cardiovascular system.
    Geriatrics, 1971, Volume: 26, Issue:9

    Topics: Animals; Blood Pressure; Cardiac Output; Cardiovascular System; Coronary Circulation; Dihydroxypheny

1971